These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 11161246)

  • 1. Influence of ABO blood groups on primary hemostasis.
    Moeller A; Weippert-Kretschmer M; Prinz H; Kretschmer V
    Transfusion; 2001 Jan; 41(1):56-60. PubMed ID: 11161246
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Use of a novel platelet function analyzer (PFA-100) with high sensitivity to disturbances in von Willebrand factor to screen for von Willebrand's disease and other disorders.
    Favaloro EJ; Facey D; Henniker A
    Am J Hematol; 1999 Nov; 62(3):165-74. PubMed ID: 10539883
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of increased von Willebrand factor levels on primary hemostasis in thrombocytopenic patients with liver cirrhosis.
    Wannhoff A; Müller OJ; Friedrich K; Rupp C; Klöters-Plachky P; Leopold Y; Brune M; Senner M; Weiss KH; Stremmel W; Schemmer P; Katus HA; Gotthardt DN
    PLoS One; 2014; 9(11):e112583. PubMed ID: 25397410
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of platelet aggregation using a point-of-care instrument in retired racing Greyhounds.
    Couto CG; Lara A; Iazbik MC; Brooks MB
    J Vet Intern Med; 2006; 20(2):365-70. PubMed ID: 16594595
    [TBL] [Abstract][Full Text] [Related]  

  • 5. von Willebrand disease in a pediatric-based population--comparison of type 1 diagnostic criteria and use of the PFA-100 and a von Willebrand factor/collagen-binding assay.
    Dean JA; Blanchette VS; Carcao MD; Stain AM; Sparling CR; Siekmann J; Turecek PL; Lillicrap D; Rand ML
    Thromb Haemost; 2000 Sep; 84(3):401-9. PubMed ID: 11019962
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The impact of bleeding history, von Willebrand factor and PFA-100(®) on the diagnosis of type 1 von Willebrand disease: results from the European study MCMDM-1VWD.
    Castaman G; Tosetto A; Goodeve A; Federici AB; Lethagen S; Budde U; Batlle J; Meyer D; Mazurier C; Goudemand J; Eikenboom J; Schneppenheim R; Ingerslev J; Habart D; Hill F; Peake I; Rodeghiero F
    Br J Haematol; 2010 Nov; 151(3):245-51. PubMed ID: 20738304
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of the platelet function analyser (PFA-100) in the characterization of patients with von Willebrand's disease and its relationships with von Willebrand factor and the ABO blood group.
    Nitu-Whalley IC; Lee CA; Brown SA; Riddell A; Hermans C
    Haemophilia; 2003 May; 9(3):298-302. PubMed ID: 12694521
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Influence of
    Pujol-Moix N; Martinez-Perez A; Sabater-Lleal M; Llobet D; Vilalta N; Hamsten A; Souto JC; Soria JM
    Int J Mol Sci; 2019 Jun; 20(13):. PubMed ID: 31262040
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The PFA-100R cannot detect blood group-dependent inhibition of platelet function by eptifibatide or abciximab at therapeutic plasma concentrations.
    Feuring M; Ruf A; Schultz A; Wehling M
    Platelets; 2010; 21(3):176-82. PubMed ID: 20121459
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Thrombostat 4000. A sensitive screening test for von Willebrand's disease.
    Weippert-Kretschmer M; Witte M; Budde U; Vigh T; Kretschmer V; Scharrer I
    Semin Thromb Hemost; 1995; 21 Suppl 2():44-51. PubMed ID: 7660157
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association of ABO(H) and I blood group system development with von Willebrand factor and Factor VIII plasma levels in children and adolescents.
    Klarmann D; Eggert C; Geisen C; Becker S; Seifried E; Klingebiel T; Kreuz W
    Transfusion; 2010 Jul; 50(7):1571-80. PubMed ID: 20210927
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High resolution multimer analysis and the PFA-100 platelet function analyser can detect von Willebrand disease type 2A without a pathological ratio of ristocetin cofactor activity and von Willebrand antigen level.
    Weiss DR; Strasser EF; Ringwald J; Zimmermann R; Eckstein R
    Clin Lab; 2012; 58(11-12):1203-9. PubMed ID: 23289190
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Perioperative monitoring of primary and secondary hemostasis in coronary artery bypass grafting.
    Hertfelder HJ; Bös M; Weber D; Winkler K; Hanfland P; Preusse CJ
    Semin Thromb Hemost; 2005; 31(4):426-40. PubMed ID: 16149021
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of ABO blood group on the collagen-binding assay for von Willebrand factor.
    Haley E; Babar N; Ritter C; Downes KA; Green D; Shurin S; Sarode R
    Am J Hematol; 2002 Nov; 71(3):229-31. PubMed ID: 12410584
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sensitive and specific assessment of recombinant von Willebrand factor in platelet function analyzer.
    Pekrul I; Kragh T; Turecek PL; Novack AR; Ott HW; Spannagl M
    Platelets; 2019; 30(2):264-270. PubMed ID: 29319374
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Severe Aortic Valve Stenosis.
    Frank RD; Lanzmich R; Haager PK; Budde U
    Clin Appl Thromb Hemost; 2017 Apr; 23(3):229-234. PubMed ID: 27481874
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The influence of the ABO blood type on the distribution of von Willebrand factor in healthy children with no bleeding symptoms.
    Akin M; Balkan C; Karapinar DY; Kavakli K
    Clin Appl Thromb Hemost; 2012 Jun; 18(3):316-9. PubMed ID: 21949039
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of PFA-100 testing and bleeding time for detecting platelet hypofunction and von Willebrand disease in clinical practice.
    Posan E; McBane RD; Grill DE; Motsko CL; Nichols WL
    Thromb Haemost; 2003 Sep; 90(3):483-90. PubMed ID: 12958618
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of ABO blood groups on tirofiban mediated inhibition of platelet function.
    Feuring M; Harenberg J; Peiter A; Ganschow A; Ruf A; Losel R; Wehling M; Schultz A
    Platelets; 2005 Nov; 16(7):430-4. PubMed ID: 16236604
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A practical concept for preoperative identification of patients with impaired primary hemostasis.
    Koscielny J; Ziemer S; Radtke H; Schmutzler M; Pruss A; Sinha P; Salama A; Kiesewetter H; Latza R
    Clin Appl Thromb Hemost; 2004 Jul; 10(3):195-204. PubMed ID: 15247976
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.